These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20196695)

  • 1. Gene therapy in hemiparkinsonian rhesus monkeys: long-term survival and behavioral recovery by transplantation of autologous human tyrosine hydroxylase-expressing neural stem cells.
    Xu Q; Jiang X; Ke Y; Zhang S; Xu R; Zeng Y
    Cytotherapy; 2010 Apr; 12(2):226-37. PubMed ID: 20196695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery of behavioral symptoms in hemi-parkinsonian rhesus monkeys through combined gene and stem cell therapy.
    Zhou Y; Sun M; Li H; Yan M; He Z; Wang W; Wang W; Lu S
    Cytotherapy; 2013 Apr; 15(4):467-80. PubMed ID: 23403361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural stem cells implanted into MPTP-treated monkeys increase the size of endogenous tyrosine hydroxylase-positive cells found in the striatum: a return to control measures.
    Bjugstad KB; Redmond DE; Teng YD; Elsworth JD; Roth RH; Blanchard BC; Snyder EY; Sladek JR
    Cell Transplant; 2005; 14(4):183-92. PubMed ID: 15929553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival and integration of neurons derived from human embryonic stem cells in MPTP-lesioned primates.
    Wakeman DR; Weiss S; Sladek JR; Elsworth JD; Bauereis B; Leranth C; Hurley PJ; Roth RH; Redmond DE
    Cell Transplant; 2014; 23(8):981-94. PubMed ID: 23562290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model.
    Takagi Y; Takahashi J; Saiki H; Morizane A; Hayashi T; Kishi Y; Fukuda H; Okamoto Y; Koyanagi M; Ideguchi M; Hayashi H; Imazato T; Kawasaki H; Suemori H; Omachi S; Iida H; Itoh N; Nakatsuji N; Sasai Y; Hashimoto N
    J Clin Invest; 2005 Jan; 115(1):102-9. PubMed ID: 15630449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Tyrosine Hydroxylase gene modified neural stem cells derived from bone marrow on Parkinson's disease--a rat model study.
    Zou Z; Jiang X; Zhang W; Zhou Y; Ke Y; Zhang S; Xu R
    Brain Res; 2010 Jul; 1346():279-86. PubMed ID: 20570658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Environmental cue-dependent dopaminergic neuronal differentiation and functional effect of grafted neuroepithelial stem cells in parkinsonian brain.
    Mine Y; Hayashi T; Yamada M; Okano H; Kawase T
    Neurosurgery; 2009 Oct; 65(4):741-53; discussion 753. PubMed ID: 19834380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease.
    Collier TJ; Sortwell CE; Elsworth JD; Taylor JR; Roth RH; Sladek JR; Redmond DE
    J Comp Neurol; 2002 Jan; 442(4):320-30. PubMed ID: 11793337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposite effects of bone marrow-derived cells transplantation in MPTP-rat model of Parkinson's disease: a comparison study of mononuclear and mesenchymal stem cells.
    Capitelli CS; Lopes CS; Alves AC; Barbiero J; Oliveira LF; da Silva VJ; Vital MA
    Int J Med Sci; 2014; 11(10):1049-64. PubMed ID: 25136260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grafts of adult subependymal zone neuronal progenitor cells rescue hemiparkinsonian behavioral decline.
    Richardson RM; Broaddus WC; Holloway KL; Fillmore HL
    Brain Res; 2005 Jan; 1032(1-2):11-22. PubMed ID: 15680936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dental pulp stem cells in MPTP-induced old-aged mice model.
    Gnanasegaran N; Govindasamy V; Simon C; Gan QF; Vincent-Chong VK; Mani V; Krishnan Selvarajan K; Subramaniam V; Musa S; Abu Kasim NH
    Eur J Clin Invest; 2017 Jun; 47(6):403-414. PubMed ID: 28369799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys: effect of levodopa and GM1 ganglioside therapy.
    Kastner A; Herrero MT; Hirsch EC; Guillen J; Luquin MR; Javoy-Agid F; Obeso JA; Agid Y
    Ann Neurol; 1994 Aug; 36(2):206-14. PubMed ID: 7914399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The therapeutic effects of tyrosine hydroxylase gene transfected hematopoetic stem cells in a rat model of Parkinson's disease.
    Zhang S; Zou Z; Jiang X; Xu R; Zhang W; Zhou Y; Ke Y
    Cell Mol Neurobiol; 2008 Jun; 28(4):529-43. PubMed ID: 17713852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic neuron-like cells derived from bone marrow mesenchymal stem cells by Lmx1α and neurturin overexpression for autologous cytotherapy in hemiparkinsonian rhesus monkeys.
    Wang WP; He ZL; Lu SY; Yan M; Zhou Y; Xie TH; Yin N; Wang WJ; Tang DH; Li HJ; Sun MS
    Curr Stem Cell Res Ther; 2015; 10(2):109-20. PubMed ID: 25300822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective action of recombinant neurturin on dopaminergic neurons in substantia nigra in a rhesus monkey model of Parkinson's disease.
    Li H; He Z; Su T; Ma Y; Lu S; Dai C; Sun M
    Neurol Res; 2003 Apr; 25(3):263-7. PubMed ID: 12739234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo magnetic resonance tracking of Feridex-labeled bone marrow-derived neural stem cells after autologous transplantation in rhesus monkey.
    Ke YQ; Hu CC; Jiang XD; Yang ZJ; Zhang HW; Ji HM; Zhou LY; Cai YQ; Qin LS; Xu RX
    J Neurosci Methods; 2009 Apr; 179(1):45-50. PubMed ID: 19428510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of dopamine neurons from embryonic stem cells in the presence of the neuralizing activity of bone marrow stromal cells derived from adult mice.
    Shintani A; Nakao N; Kakishita K; Itakura T
    J Neurosci Res; 2008 Oct; 86(13):2829-38. PubMed ID: 18561325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial stem cell transplantation in MPTP- exposed primates: an alternative cell source for treatment of Parkinson's disease.
    Wolff EF; Mutlu L; Massasa EE; Elsworth JD; Eugene Redmond D; Taylor HS
    J Cell Mol Med; 2015 Jan; 19(1):249-56. PubMed ID: 25283241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic-like neurons derived from oral mucosa stem cells by developmental cues improve symptoms in the hemi-parkinsonian rat model.
    Ganz J; Arie I; Buch S; Zur TB; Barhum Y; Pour S; Araidy S; Pitaru S; Offen D
    PLoS One; 2014; 9(6):e100445. PubMed ID: 24945922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of striatal transplantation of cells transfected with GDNF gene without pre- and pro-regions in mouse model of Parkinson's disease.
    Revishchin A; Moiseenko L; Kust N; Bazhenova N; Teslia P; Panteleev D; Kovalzon V; Pavlova G
    BMC Neurosci; 2016 Jun; 17(1):34. PubMed ID: 27286696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.